In the absence of government regulations, many companies have developed their own guidelines for development of nanomaterials. In this article, Richard A. Liroff, founder and director of the Investor Environmental Health Network, suggests key questions companies need to ask themselves while performing due diligence, including covering supplier issues, life-cycle considerations and real-world safety assessments.

Full Story:

Related Summaries